SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?


To: tonyt who wrote (415)11/5/1997 10:16:00 AM
From: AJAG  Read Replies (2) | Respond to of 1972
 
I believe Michael Murphy has a target of 100 dollars per share on VICL. I don't know the time frame. Murphy, who manages a biotech fund, based his projection on revenues from licensing the big
pharmaceutical co.s (like Merck).